Scientific illustration showing intestinal tuft cells signaling the brain via acetylcholine, serotonin, and the vagus nerve to suppress appetite during parasitic infections.
Scientific illustration showing intestinal tuft cells signaling the brain via acetylcholine, serotonin, and the vagus nerve to suppress appetite during parasitic infections.
Image generated by AI

Intestinal cells signal brain to curb hunger during parasitic infections

Image generated by AI

A team led by David Julius, the 2021 Nobel Prize winner in Medicine, has described the molecular mechanism by which intestinal tuft cells signal the brain to suppress appetite during parasitic infections. Published today in Nature, the study identifies communication via acetylcholine and serotonin that activates the vagus nerve. The finding could aid treatments for conditions like irritable bowel syndrome.

David Julius's team at the University of California, San Francisco (UCSF), has traced the pathway linking the intestinal immune system to the brain during parasitic worm infections. Tuft cells detect parasites via succinate and release acetylcholine in two phases: an initial brief burst and a sustained release after full immune response. This acetylcholine stimulates enterochromaffin (EC) cells, which release serotonin and activate vagus nerve fibers to the brain, causing appetite loss akin to gastroenteritis, according to the study published Wednesday in Nature. First author Koki Tohara explained: “Tuft cells do something neurons do, but through a completely different mechanism,” using acetylcholine without typical neuronal machinery. Julius noted: “The gut waits to confirm the threat is real and persistent before telling the brain to change your behavior,” explaining delayed symptoms. Coauthor and UCSF immunologist Richard Locksley highlighted interest in how these non-synaptically connected cells alter behavior. Mouse experiments confirmed the mechanism: animals with intact tuft cells ate less, while genetically modified ones lacking acetylcholine production maintained normal intake. The authors suggest applications for managing infection responses and conditions like food intolerances or chronic visceral pain, as tuft cells exist in other epithelia like airways. Spanish experts such as Félix Viana from the Alicante Institute of Neurosciences call it “interesting” and relevant for defenses in other tissues, while José Luis Trejo from the Cajal Neuroscience Center views it as a “sensory interface” with therapeutic potential.

What people are saying

Initial reactions on X to the Nature study on intestinal tuft cells signaling the brain to curb hunger during parasitic infections are positive and informative. Nutritionists and scientists shared summaries in English and Spanish, highlighting the role of acetylcholine and serotonin via the vagus nerve. Posts linked to the study and ScienceDaily, noting potential IBS treatment implications. Some connected findings to vagus nerve function and gut-brain axis.

Related Articles

Scientists in a lab visualize VLK enzyme from neurons enabling targeted pain relief, shown with 3D neuron model and mouse pain reduction experiment.
Image generated by AI

Researchers pinpoint enzyme that could enable safer pain relief

Reported by AI Image generated by AI Fact checked

Scientists at Tulane University and collaborating institutions have found that neurons release an enzyme called vertebrate lonesome kinase (VLK) outside cells to help switch on pain signals after injury. Removing VLK from pain-sensing neurons in mice sharply reduced post-surgical pain–like responses without impairing normal movement or basic sensation, according to a study in Science, suggesting a potential new route to more targeted pain treatments.

Researchers have discovered a cluster of sensory neurons that link the brain and heart, triggering an immune response crucial for recovery after a heart attack. This finding reveals a feedback loop involving the nervous and immune systems that could lead to new therapies. Experiments in mice showed that manipulating these neurons speeds up healing and reduces scarring.

Reported by AI Fact checked

Researchers at the Massachusetts Institute of Technology report that intelectin-2, a carbohydrate-binding lectin found in the gastrointestinal tract, can both crosslink mucus components to reinforce the gut’s protective barrier and bind certain bacteria, restricting their growth and reducing viability—findings that may inform future approaches to drug-resistant infections and inflammatory bowel disease.

An international team of researchers has identified trimethylamine (TMA), a gut microbe metabolite produced from dietary nutrients such as choline, as a compound that inhibits the immune-signalling protein IRAK4, dampening inflammation and improving insulin action in experimental models. The discovery, reported in Nature Metabolism, suggests a potential new way to counter some of the harmful metabolic effects of high-fat diets and opens avenues for future type 2 diabetes therapies, a disease affecting more than 500 million people worldwide.

Reported by AI Fact checked

Researchers at Cincinnati Children's Hospital Medical Center have found that certain macrophages, a type of immune cell, can form rapid, neuron-like connections with muscle fibers to speed healing. By delivering quick pulses of calcium into damaged muscle, these cells trigger repair-related activity within seconds. The findings, published online November 21, 2025, in Current Biology, could eventually inform new treatments for muscle injuries and degenerative conditions.

Researchers at Weill Cornell Medicine report that tumors exploit a CD47–thrombospondin-1 signal to push T cells into exhaustion, and that interrupting the interaction restores T cell activity and slows tumor growth in mouse models. The study was published on November 17, 2025, in Nature Immunology.

Reported by AI

Researchers at the University of Victoria have discovered that the protein Reelin could help repair leaky gut caused by chronic stress and alleviate depression symptoms. A single injection restored Reelin levels in preclinical models, showing antidepressant effects. The findings highlight the gut-brain connection in mental health.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline